The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015
CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015
Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB) Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013
Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Diagnosis of latent tuberculosis infection in children with the useof different immunological methods Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection Source: International Congress 2015 – Latent TB infection and screening Year: 2015
Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients? Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
Comparison of tuberculin skin test and in-vitro interferon gamma release tests in diagnosis of tuberculosis in children with household tuberculosis contact Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014
The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection Source: International Congress 2016 – Latent tuberculosis infection Year: 2016
Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015
Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014
The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010